Trained as an Internal Family Systems practitioner, this model contains attachment theory, polyvagal theory, somatic and trauma informed stabilisation. From personal experience, I know I can guide you ...
Comprehensive guide to starting MEK inhibitor therapy for NF1, covering preparation, dosing, pharmacy logistics, side effects, and management tips for patients.
In 2024, Mirum announced positive interim results from the Phase 2b VANTAGE study of volixibat in PBC. No new safety signals were observed in the study. Volixibat has been granted FDA Breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results